Yousef Zakharia
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC) (NCT03324373) | Yousef Zakharia | 2019-03-20 |
| A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer (NCT03575013) | Yousef Zakharia | 2018-10-29 |
Track Yousef Zakharia automatically
Every clearance here is in the API, with alerts when new ones post.